Clinical Trial Update: Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing how different thromboplastin reagents affect prothrombin time in patients with isolated extrinsic pathway factor deficiency or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Disorders
• Liver Disease

Drugs mentioned

• Thromboplastin reagent (thromboplastin reagent)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Hemorrhagic Disorders | Phase 4 | Status: NOT_YET_RECRUITING